Connect with us

Health

American College of Pediatricians issues fiery statement condemning child gender transition

Published

on

American College of Pediatricians issues fiery statement condemning child gender transition

Join Fox News for access to this content

You have reached your maximum number of articles. Log in or create an account FREE of charge to continue reading.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

A coalition of pediatricians, health policy groups and conservative organizations is calling on medical professionals to stop promoting transgender medical treatments for children.

The American College of Pediatricians (ACP) and allied groups styling themselves as “Doctors Protecting Children” have published a declaration urging mainstream American medical associations like the American Academy of Pediatrics to abandon support for so-called “gender-affirming care” for transgender youths.

Advertisement

“As physicians, together with nurses, psychotherapists and behavioral health clinicians, other health professionals, scientists, researchers, and public health and policy professionals, we have serious concerns about the physical and mental health effects of the current protocols promoted for the care of children and adolescents in the United States who express discomfort with their biological sex,” the declaration states.

Affirming that sex is a biological characteristic and that medical decisions “should not be based upon an individual’s thoughts and feelings,” including their self-professed “gender identity,” the groups assert that what is currently accepted as best practice treatments for gender dysphoria is actually harmful for patients. Their view is disputed by the larger medical community, which has established that gender is a social construct, not an inborn biological realty, and that validation and affirmation of a person’s internal self-identity are in their best interest. 

‘GENDER-AFFIRMING’ TREATMENTS DON’T BENEFIT YOUTH, SAYS PEDITRICIANS GROUP: ‘IRREVERSIBLE CONSEQUENCES’

A coalition called “Doctors Protecting Children” argues that puberty blockers, cross-sex hormone treatments and other “gender-affirming care” for transgender children and adolescents lack evidence showing their effectiveness as treatments for gender dysphoria.  (Adobe Stock)

The American Medical Association (AMA), for instance, states on its website that “improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.” 

Advertisement

“Receipt of gender-affirming care has been linked to dramatically reduced rates of suicide attempts, decreased rates of depression and anxiety, decreased substance use, improved HIV medication adherence and reduced rates of harmful self-prescribed hormone use,” the APA claims.

The federal government, through the Department of Health and Human Services, also supports transgender medical procedures for children and adolescents, calling it a “supportive form of health care that may include medical, surgical, mental health and non-medical services for transgender and nonbinary people.” 

“Research demonstrates that gender-affirming care improves the mental health and overall well-being of gender-diverse children and adolescents,” the Office of Population Affairs (OASH) at HHS has said.

However, several European countries, including the U.K., Sweden, Finland, Norway and France, have pushed back on the use of puberty blockers and sex reassignment surgery for children and adolescents. The U.K. last year, for instance, announced a rollback on the availability of hormone treatments, limiting them to clinical trials exclusively.

TRANS CHILDREN WHO TOOK PUBERTY-BLOCKING DRUGS HAD MENTAL HEALTH ISSUES, UK STUDY FOUND

Advertisement

Trans rights activists take part in a protest against the ban on hormone blockers on April 20, 2024, in London. (Carl Court/Getty Images)

In contrast to the World Professional Association for Transgender Health (WPATH) standards of care for transsexual, transgender and gender-nonconforming people, Doctors Protecting Children argues that permitting children to socially transition before puberty does not improve their mental health and social well-being outcomes. 

The declaration cites various studies to support its claims, including the Cass Review, a controversial independent report commissioned by the United Kingdom’s National Health Service that documented practices and care for children reporting gender identity disorders.

Named for its primary author, Dr. Hilary Cass, the 388-page review found medical professionals reported “no guidance, no evidence, no training” regarding gender disorders and were “afraid” to discuss the topic. It concluded that evidence supporting transgender medical treatments for children and adolescents was “remarkably weak.” 

The Cass Review has been criticized by WPATH and transgender rights groups, which claim it ignored recent evidence that supports transgender medical procedures as beneficial for transgender minors and made “assumptions about transgender children and adolescents which are outdated and untrue, which then form the basis of harmful interventions.”

Advertisement

EXPOSING THE TRANS AGENDA AIMED AT OUR KIDS: FAITH LEADER REVEALS HOW PARENTS CAN KEEP CHILDREN SAFE

Doctors Protecting Children cited several studies that show puberty-blocking drugs did not have significant benefits for young people experiencing gender dysphoria. (iStock)

Doctors Protecting Children said the Cass Review and related research from the University of York “further demonstrate the failure of the WPATH, American Academy of Pediatrics and Endocrine Society protocols.” 

The coalition argues that research shows there is a lack of evidence that social transition in childhood has any positive or negative mental health outcomes; that puberty blockers succeed in suppressing secondary sex characteristics but demonstrate “no changes in gender dysphoria or body satisfaction”; and that there is insufficient research on the long-term effects of cross-sex hormone therapies to determine if they are beneficial or harmful.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“Psychotherapy for underlying mental health issues such as depression, anxiety, and autism, as well as prior emotional trauma or abuse should be the first line of treatment for these vulnerable children experiencing discomfort with their biological sex,” Doctors Protecting Children states.

The coalition calls on the American Academy of Pediatrics, the Endocrine Society, the Pediatric Endocrine Society, the American Medical Association, the American Psychological Association and the American Academy of Child and Adolescent Psychiatry to “follow the science and their European professional colleagues and immediately stop the promotion of social affirmation, puberty blockers, cross-sex hormones and surgeries for children and adolescents who experience distress over their biological sex (emphasis original).”

“It is time that these American medical institutions follow the science and the lead of our European professional colleagues and cease to promote protocols that harm children, including the promotion of social affirmation, puberty blockers, cross-sex hormones and surgeries for children and adolescents who experience distress over their biological sex,” said Dr. Jill Simons, pediatrician and executive director of the American College of Pediatricians. 

AAP, the Endocrine Society, the Pediatric Endocrine Society, AMA, APA and AACAP did not immediately respond to requests for comment. 

Advertisement

More than a dozen Republican-led states, including Texas, have already acted to ban or limit the use of puberty blockers on minors, with fierce opposition from American medical groups. 

Fox News Digital’s Melissa Rudy, Anders Hagstrom and Timothy H.J. Nerozzi contributed to this report.

For more Health articles, visit www.foxnews.com/health.

Health

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

Published

on

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

NEWYou can now listen to Fox News articles!

POST-DOSE PATTERN — New research reveals why the COVID vaccine can trigger heart issues, especially in one group

PREVENTION PAYOFF — Simple lifestyle changes could slash heart attack risk for millions

A new study has identified why mRNA COVID-19 vaccines could trigger heart issues, especially in one demographic. (iStock)

SMOKE SCREEN — A major cannabis study finds little proof for popular medical claims and flags big dangers

Advertisement

HIDDEN LINK — A common dental health issue may hint at a dangerous cardiovascular condition

SIGN UP FOR OUR HEALTH NEWSLETTER

SCREENING DEBATE A new study questions whether annual mammograms are necessary for most women

SUPER SPREAD — An “aggressive” new flu variant sweeps the globe as doctors warn of severe symptoms

The flu season has intensified as the new H3N2 variant causes severe illness worldwide. (iStock)

Advertisement

DANGEROUS DEFICIT — A nutrient deficiency has been linked to heart disease risk for millions

LIKE WHAT YOU’RE READING? CLICK HERE FOR MORE HEALTH NEWS

CORONARY CHRISTMAS — Holiday heart attacks spike as doctors share hidden triggers and prevention tips

Continue Reading

Health

Aging-related joint disorder increasingly affects people under 40, study finds

Published

on

Aging-related joint disorder increasingly affects people under 40, study finds

NEWYou can now listen to Fox News articles!

Cases of gout are rising in younger individuals, according to a global study.

The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021, researchers in China announced.

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

Advertisement

The study, published in the journal Joint Bone Spine, investigated 2021 data from the Global Burden of Disease (GBD), spanning 204 countries within the 30-year timeframe.

The data measured gout prevalence, incidence and years lived with disability, tracking global trends over time. The results showed a global increase across all three outcomes.

Gout is expected to continue rising in young people through 2035. (iStock)

Prevalence and disability years increased by 66%, and incidence rose by 62%. In 2021, 15- to 39-year-olds accounted for nearly 14% of new gout cases globally, the study found.

Men from 35 to 39 years old and people in high-income regions had the highest burden, but high-income North America topped the list for highest rates.

Advertisement

‘SKINNY FAT’ WARNING ISSUED AS STUDY FINDS HIDDEN OBESITY BEHIND NORMAL BMI

Men were also found to have lived more years with gout due to high BMI, while women tended to have the condition as a link to kidney dysfunction, the study noted.

The total number of cases is expected to increase globally due to population growth, but the study projected that rates per population would decrease.

The researchers noted that data quality, especially in low-income settings, could have posed a limitation to the broad GBD data.

What is gout?

Gout is a common form of arthritis involving sudden and severe attacks of pain, swelling, redness and tenderness in the joints, according to Mayo Clinic. It most often occurs in the big toe.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The condition occurs when urate crystals accumulate in the joint. These form when there are high levels of uric acid in the blood, which the body produces when it breaks down a natural substance called purines.

A gout flare-up can happen at any time, often at night, causing the affected joint to feel hot, swollen, tender and sensitive to the touch.

Urate crystals, described as sharp and needle-like, build up in the joint, causing intense pain and swelling. (iStock)

Purines can also be found in certain foods, like red meat or organ meats like liver and some seafood, including anchovies, sardines, mussels, scallops, trout and tuna, according to the Mayo Clinic. Alcoholic drinks, especially beer, and drinks sweetened with fruit sugar can also lead to higher uric acid levels.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Uric acid will typically dissolve in the blood and pass through the kidneys into urine, but when the body produces too much or too little uric acid, it can cause a build-up of urate crystals. These are described by the Mayo Clinic as sharp and needle-like, causing pain, inflammation and swelling in the joint or surrounding tissue.

Risk factors for gout include a diet rich in high-purine foods and being overweight, which causes the body to produce more uric acid and the kidneys to have trouble eliminating it.

Experts urge patients to seek medical attention for gout flare-ups. (iStock)

Certain conditions like untreated high blood pressure, diabetes, obesity, metabolic syndrome and heart and kidney diseases can increase the risk of gout, as well as certain medications.

Advertisement

A family history of gout can also increase risk. Men are more likely to develop the condition, as women tend to have lower uric acid levels, although symptoms generally develop after menopause.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Untreated gout can cause worsening pain and joint damage, experts caution. It may also lead to more severe conditions, such as recurrent gout, advanced gout and kidney stones.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The Mayo Clinic advises patients to seek immediate medical care if a fever occurs or if a joint becomes hot and inflamed, which is a sign of infection. Certain anti-inflammatory medications can help treat gout flares and complications.

Advertisement

Fox News Digital reached out to the researchers for comment.

Continue Reading

Health

New study questions whether annual mammograms are necessary for most women

Published

on

New study questions whether annual mammograms are necessary for most women

NEWYou can now listen to Fox News articles!

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography.

The WISDOM randomized clinical trial, led by study authors from universities and healthcare systems across the U.S., considered more than 28,000 women aged 40 to 74 years old, splitting them into a risk-based screening group and an annual mammography group.

ERIN ANDREWS HAD ‘NO SYMPTOMS’ BEFORE CANCER DIAGNOSIS, PUSHES FOR EARLY SCREENINGS

Advertisement

Researchers calculated each woman’s individual risk based on genetics (sequencing of nine breast cancer genes) and other health factors. 

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer. (iStock)

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. Patients with elevated risk were told to get an annual mammography and counseling.

Average-risk women were guided to get mammograms every two years, while low-risk individuals were advised to have no screening until they became higher risk or reached age 50.

HIDDEN TYPE OF BREAST CANCER COULD BE EXPOSED BY NEW BREAKTHROUGH TECH

Advertisement

The researchers found that risk-based screening did not lead to more advanced cancer diagnoses (stage 2B or higher) compared with annual screening, indicating that it is just as safe as traditional methods. The risk-based approach, however, did not reduce the number of biopsies overall, as researchers had hoped.

Among the risk-based group of women, those with higher risk had more screening, biopsies and detected cancers. Women at lower risk had fewer procedures.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography. (iStock)

“[The] findings suggest that risk-based breast cancer screening is a safe alternative to annual screening for women aged 40 to 74 years,” the researchers noted in the research summary. “Screening intensity matched individual risk, potentially reducing unnecessary imaging.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Fox News medical contributor Dr. Nicole Saphier, associate professor of radiology at Memorial Sloan Kettering Cancer Center in New Jersey, commented that while these findings are important, the study “completely sidelines” what screenings are designed to do — detect cancer early.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“If you don’t measure stage 0, stage 1 or stage 2A cancers, you can’t tell whether personalized screening delays diagnosis in a way that matters for survival and treatment intensity,” Saphier, who was not involved in the study, told Fox News Digital in an interview.

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. (iStock)

More than 60% of breast cancers in the U.S. are diagnosed at stage 1 or 2A, where cure rates exceed 90%, the doctor noted.

Advertisement

The trial doesn’t “fully evaluate” whether risk-based screening changes detection at the earliest and most treatable stages, where screening “delivers its greatest benefit,” according to Saphier.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Mammography is not without risk — radiation exposure, false positives, anxiety and potential over-diagnosis are real and should be acknowledged,” she said. “But it remains the most effective, evidence-based tool for detecting breast cancer early, when treatment is most successful.”

The expert added that labeling women under 50 as “low risk” is “outdated,” as breast cancer diagnoses are on the rise in younger females.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“Until long-term mortality data support alternative approaches, annual screening beginning at 40 for average risk women should continue,” Saphier added. “Women should be assessed for breast cancer risk by 25 years old to determine if screening should begin earlier.”

Continue Reading

Trending